Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN), a biotechnology company focused on progressing Psychedelics to Therapeutics™, is pleased to announce that...
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada The post Field Trip facilitates beneficial...
Core One Labs Inc. (CSE: COOL | OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) announces that it has initiated rollout of its commercial sales strategy...
CURE Pharmaceutical Holding Corp. (OTC: CURR), a proprietary broad platform and wellness technology company, today announced results for the quarter ended June...
Are these penny stocks to buy now or avoid in September? The post Best Penny Stocks To Buy Now? 4 To Watch This Month appeared first...
The article Mydecine Sells Mindleap Health for $4 Million was originally published on Microdose. We’ve been reporting on the apparent troubles over...
Mydecine sells Mindleap and gets a much-needed cash infusion. The post Mydecine Sells Mindleap For C$4 Million appeared first on Green Market Report.
The launch of analyst coverage of psychedelics is a sign of how big the industry could become and why it is worth watching more closely now....
Balance Sheet and Governance Strengthened with Asset Sale and Board Appointments New Marketing Programs Showing Encouraging Early Results OXNARD, Calif.,...
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program The post Filament administers psilocybin...